Anicells’ mission is to accelerate and facilitate the go-to-patient process of novel cell therapy products by providing:
Regulatory Support
Assistance in the regulatory requirements for filing your product to the authorities
Development on Demand
GMP translation of the
cell therapy process
GMP Manufacturing
Production of the cell therapy product for clinical trials
Next Generation Process Development
Cell therapy process review and design for upscaling, outscaling and lean manufacturing
Oktober is de borstkankermaand. Nog steeds krijgt 1 op 7 vrouwen er ooit mee te maken. Dit aantal moet dalen. Preventie, waaronder beweging, is belangrijk.
Although anicells has been up and running for a year, Thursday 30/9 was the time to celebrate. Nathalie Cools, CEO and founder of anicells, along
Regeneratieve geneeskunde, dat als doel heeft om falend weefsel te herstellen, is in een versnelling gekomen. Dat is ook het tijdschrift Knack/Trends niet ontgaan. Zij
